132 related articles for article (PubMed ID: 38432708)
1. Letter in Response to Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
Jenrette JE; Lebin JA
J Emerg Med; 2024 Feb; 66(2):262-263. PubMed ID: 38432708
[No Abstract] [Full Text] [Related]
2. Rivastigmine for the management of anticholinergic delirium.
Chiew AL; Holford AG; Chan BSH; Isoardi KZ
Clin Toxicol (Phila); 2024 Feb; 62(2):82-87. PubMed ID: 38465631
[TBL] [Abstract][Full Text] [Related]
3. Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
Fratta KA; Ginder M; Haggerty DA
J Emerg Med; 2023 Oct; 65(4):e366-e368. PubMed ID: 37716903
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Anticholinergic Delirium with Oral Rivastigmine: A Case Report.
Karousatos C; Murphy L
J Emerg Med; 2024 May; 66(5):e589-e591. PubMed ID: 38658202
[TBL] [Abstract][Full Text] [Related]
5. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
Whitledge JD; Watson CJ; Simpson M; Bakkar A; Boussi L; Scott M; Boyle KL
J Med Toxicol; 2023 Apr; 19(2):219-223. PubMed ID: 36575250
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine Use in the Treatment of Antimuscarinic Delirium.
Greene SC
J Med Toxicol; 2023 Jul; 19(3):284-287. PubMed ID: 37204613
[No Abstract] [Full Text] [Related]
7. Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.
Hughes AR; Moore KK; Mah ND; Birmingham AR; Clark RK; Thompson JA; Hendrickson RG
Clin Toxicol (Phila); 2021 Sep; 59(9):855-856. PubMed ID: 33576254
[No Abstract] [Full Text] [Related]
8. Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.
Van Kernebeek MW; Ghesquiere M; Vanderbruggen N; Verhoeven E; Hubloue I; Crunelle CL
Clin Toxicol (Phila); 2021 May; 59(5):447-448. PubMed ID: 32960128
[No Abstract] [Full Text] [Related]
9. A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.
Oldenbeuving AW; de Kort PL; Jansen BP; Kappelle LJ; Roks G
BMC Neurol; 2008 Sep; 8():34. PubMed ID: 18803862
[TBL] [Abstract][Full Text] [Related]
10. Case series profile of olanzapine post-injection delirium/sedation syndrome.
Seebaluck J; Downes MA; Brown J; Harris K; Isoardi KZ; Chan BS
Br J Clin Pharmacol; 2023 Feb; 89(2):903-907. PubMed ID: 36349832
[TBL] [Abstract][Full Text] [Related]
11. Rivastigmine in the treatment of delirium in older people: a pilot study.
Overshott R; Vernon M; Morris J; Burns A
Int Psychogeriatr; 2010 Aug; 22(5):812-8. PubMed ID: 20353624
[TBL] [Abstract][Full Text] [Related]
12. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase inhibitors for the treatment of delirium in non-ICU settings.
Yu A; Wu S; Zhang Z; Dening T; Zhao S; Pinner G; Xia J; Yang D
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012494. PubMed ID: 29952000
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease.
Cagnin A; Cester A; Costa B; Ermani M; Gabelli C; Gambina G;
Neurol Sci; 2015 Mar; 36(3):457-63. PubMed ID: 25394739
[TBL] [Abstract][Full Text] [Related]
15. The impact of rivastigmine on post-surgical delirium and cognitive impairment; a randomized clinical trial.
Massoudi N; Mohit B; Fathi M; Nooraei N; Hannani KK; ArianNik M
Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5970. PubMed ID: 37485727
[TBL] [Abstract][Full Text] [Related]
16. Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease.
Scicutella A
J Neuropsychiatry Clin Neurosci; 2015; 27(1):e90. PubMed ID: 25716514
[No Abstract] [Full Text] [Related]
17. Improper Application of a Rivastigmine Patch to the Back of the Neck Induced Toxic Symptoms.
Matsuzono K; Mita Y; Imai G; Fujimoto S
Intern Med; 2023 Nov; 62(21):3247-3250. PubMed ID: 36948626
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of anticholinergic delirium - theory, evidence and practice.
Dawson AH; Buckley NA
Br J Clin Pharmacol; 2016 Mar; 81(3):516-24. PubMed ID: 26589572
[TBL] [Abstract][Full Text] [Related]
19. A differential diagnosis for annular lesions: contact dermatitis to transdermal rivastigmine patches.
Khoo ABS; Haque-Hussain S
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30077968
[No Abstract] [Full Text] [Related]
20. Angioedema Caused by Rivastigmine Patch: A Rare Case.
Naharci MI; Tasci I
J Clin Psychopharmacol; 2018 Jun; 38(3):281-282. PubMed ID: 29620690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
